JMDC Inc. (TSE:4483) agreed to acquire Cancer Scan Co., Ltd. for ¥ 14000 million on December 28, 2023. JMDC Inc. (TSE:4483) will acquire 0.11 million shares of Cancer Scan Co., Ltd. The total assets were ¥ 2695 million, net assets were ¥ 2,097 million, revenue was ¥ 4,177 million, operating profit was ¥ 696 million and net income was ¥ 454 million for year ending May 31, 2023 of Cancer Scan Co., Ltd. The deal is expected to be closed on January 31, 2024.